Clinical Trial Update: A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431) [Phase 2]

View source ↗

Summary

A completed Phase 2 double-blind trial evaluated E2020 (donepezil hydrochloride) in patients with dementia with Lewy bodies; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies

Drugs mentioned

• E2020 (Donepezil hydrochloride) (Donepezil hydrochloride)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Dementia With Lewy Bodies (DLB) | Phase 2 | Status: COMPLETED | Results posted: 2013-02-18